Tsuyoshi Isawa, Yusuke Toki, Masataka Taguri, Norio Tada, Shigeru Toyoda
{"title":"Transcatheter Strategy for Severe Mitral Regurgitation Requiring Percutaneous Ventricular Assist Device Support.","authors":"Tsuyoshi Isawa, Yusuke Toki, Masataka Taguri, Norio Tada, Shigeru Toyoda","doi":"10.1253/circrep.CR-26-0155","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Data on transcatheter strategies in patients with severe mitral regurgitation (MR) and advanced chronic heart failure requiring Impella support remain limited.</p><p><strong>Methods and results: </strong>We retrospectively analyzed 33 patients with severe MR and advanced chronic heart failure requiring Impella support, treated with a transcatheter strategy (n=17) or a conservative strategy (n=16). In an overlapweighted Cox model, the transcatheter strategy was associated with a lower in-hospital mortality rate (hazard ratio, 0.13; 95% confidence interval, 0.03-0.52; P=0.004).</p><p><strong>Conclusions: </strong>A transcatheter strategy had survival benefit for this high-risk population.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"8 9","pages":"1570-1572"},"PeriodicalIF":2.3000,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13558270/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1253/circrep.CR-26-0155","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/10 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Data on transcatheter strategies in patients with severe mitral regurgitation (MR) and advanced chronic heart failure requiring Impella support remain limited.
Methods and results: We retrospectively analyzed 33 patients with severe MR and advanced chronic heart failure requiring Impella support, treated with a transcatheter strategy (n=17) or a conservative strategy (n=16). In an overlapweighted Cox model, the transcatheter strategy was associated with a lower in-hospital mortality rate (hazard ratio, 0.13; 95% confidence interval, 0.03-0.52; P=0.004).
Conclusions: A transcatheter strategy had survival benefit for this high-risk population.